CU Cancer Center adds 18 members

The University of Colorado Cancer Center, Colorado’s only federally designated comprehensive cancer, is pleased to announce that the following scientists have been approved as members of our organization, bringing the total to 440. Our goal is to connect cancer researchers in Colorado for collaboration and to translate basic findings into new tests, treatments and therapies for cancer, and to provide the infrastructure necessary for efficient, effective research for Colorado cancer scientists.

Dara Aisner, MD, PhD, Associate Member, Lung, Head and Neck Cancer Program

Assistant Professor, Pathology, University of Colorado School of Medicine
Associate Director, Colorado Molecular Correlates Laboratory, University of Colorado Anschutz Medical Campus

  • Working in GI Cancer, Head & Neck Cancer, Thoracic Oncology
  • Research Focus: collaborative projects evaluating biomarker identification and validation, with emphasis on markers to predict likelihood of disease development in precancerous states, to predict response to pathway-specific targeted therapy and to predict disease prognosis.
  • Select Current Funding: CAP Foundation Research Grant, “Identification and Validation of Gene Targets for CpG promoter Methylation for Risk Stratification in GIST
  • Select Publications in Leuk Lymphoma, Hum Pathol
  • Collaborators: Drs. Ross Camidge, Gail Eckhardt and Antonio Jimeno
  • Education: PhD, University of Texas Southwestern; MD, University of Texas Southwestern; Resident/Clinical Fellow, National Institutes of Health; Fellowship in Surgical Pathology, University of Pennsylvania Hospital; Fellowship in Molecular and Genetic Pathology, University of Pennsylvania Hospital.

David Barton, PhD, Member, Molecular Oncology Program

Associate Professor, Microbiology, University of Colorado School of Medicine

  • Working in GI Cancer and general cancer
  • Research Focus: Positive-strand RNA viruses, including hepatitis C virus and liver cancer
  • Collaborators: Drs. Jeffrey Kieft, Kirk Hansen
  • Recent Publications in RNA, Journal of Virology and Virus Research
  • Select Current Funding: NIH R01, “Enterovirus RNA Translation and Replication”
  • Education: PhD, Microbiology, Medical College of Ohio

Gerrit Bouma, PhD, Associate Member, Molecular Oncology Program

Assistant Professor, Animal Reproduction & Biotechnology Laboratory, Colorado State University

  • Working in GYN Oncology
  • Research Focus: Genetic pathways controlling fetal gonad development. Role of microRNAs in gene regulation. Role of stem cells and microRNA in ovarian cancer development and metastasis.
  • Collaborator: Dr. Monique Spillman
  • Select Current Funding: NIH NICHHD R03, “Regulation of ovarian development by GATA4.”
  • Select Recent Publications in Endocrinology, Biol Reprod
  • Education: PhD, Zoology, University of Idaho. Postdoctoral Fellowship, The Jackson Laboratory

James Dearing, PhD, Member, Cancer Prevention & Control Program

Senior Scientist, Kaiser Permanente Colorado Institute for Health Research
Director, Cancer Research Network Cancer Communication Research Center, Kaiser Permanente Colorado

  • Working in cancer communication research
  • Research Focus: Organizational sociology, inter-organizational theory and networks and social change, related to cancer care and prevention-related interventions.
  • Select Current Funding: NCI Center of Excellence in Cancer Communications Research grant, Bill & Melinda Gates Foundation, and several other grants from NCI, CDC and CCTSI
  • Select Publications in Patient Edu and Counseling, Translational Behavioral Medicine, Clinical Med and Research
  • Education: PhD, Communication Theory and Research, University of Southern California

Thomas Delate, PhD, Associate Member, Cancer Prevention & Control Program

Clinical Instructor, Clinical Pharmacy, University of Colorado School of Pharmacy
Scientist, Clinical Pharmacy Research Department, Kaiser Permanente Colorado

  • Working in Breast Cancer, Hereditary Cancer, Cancer Survivorship
  • Research Focus: Effects of cancer therapy, including pharmacotherapy. Molecular tumor markers as prediction of chemotherapy response
  • Select Publications in Annals of Pharmacotherapy and Medical Care
  • Education: PhD, Pharmaceutical Sciences, University of Arizona. MS, Biophysics and Genetics, University of Colorado Health Sciences Center

Heather Feigelson, Member, Cancer Prevention & Control Program

Investigator, Institute for Health Research, Kaiser Permanente Colorado

  • Working in Breast Cancer, GI Cancer, Hereditary Cancer
  • Research Focus: Genetic susceptibility and genomics, cancer survivorship, steroid hormone metabolism and lifestyle factors and cancer risk.
  • Select Publications in Hum Mol Genet, Int J Cancer, J Clin Endocrinol Metab
  • Select Current Funding: NCI/NIH U01, “Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.” NCI RC1, “Improving Breast Cancer Surgery Quality through a Qualitative Surgery Database.”
  • Education: PhD, Epidemiology, University of California, Los Angeles. MPH, Epidemiology, San Diego State University

Todd Hankinson, Associate Member, Cancer Prevention & Control Program

Assistant Professor, Pediatric Neurosurgery, University of Colorado School of Medicine and The Children’s Hospital

  • Working in Neurologic Oncology, Pediatric Oncology
  • Research Focus: Clinical outcomes research, including establishing the first multi-institutional database for pediatric patients with craniopharyngioma
  • Collaborators: Drs. Nicholas Foreman and Rajeev Vibhakar
  • Select Publications in Child’s Nerv Syst., Neurosurgery, J Neurosurg Pediatrics
  • Education: MD, Columbia University. MBA, University of Oxford, Oxford, UK. Internship and Residency, New York-Presbyterian Hospital. Fellowship in Pediatric Neurosurgery, University of Alabama, Birmingham.

Ryan Hansen, PhD, Associate member, Developmental Therapeutics Program

Research Scientist II, Colorado State University Animal Cancer Center

  • Works in: Developmental Therapeutics
  • Research Focus: Orthotopic models of cancer to investigate novel chemotherapeutic therapies and novel combinations of current therapeutics
  • Collaborators: Dr. Dan Gustafson
  • Select Funding: Cancer Supercluster at Colorado State University, “Carboxylesterase-activated Doxazolidine-produgs for hepatocellular Carcinoma.”
  • Select Publications in Clinical Cancer Research, Veterinary and Comparative Oncology and Journal of Chromatography
  • Education: PhD, Cancer Biology, University of Chicago. Postdoctoral Fellowship in Pharmaceutical Sciences, University of Colorado School of Medicine. Postdoctoral Fellowship in Pharmacology, Colorado State University.

Jay Hesselberth, PhD, Associate Member, Molecular Oncology Program

Assistant Professor, Biochemistry & Molecular Genetics, University of Colorado School of Medicine

  • Working in basic cancer research
  • Research Focus: Molecular mechanisms of cancer including microRNA-mRNA interactions in different cancer settings, and identifying sites in the genome that are prone to somatic mutation and hypermutation
  • Collaborators: Drs. Manoj Pillai, Peter Kabos, James DeGregori and James Hagman
  • Select Current Funding: University of Colroado/Butcher Foundation grant, “Genome-wide mapping of chromatin topology in budding yeast.”
  • Select Publications in Genome Res, Mol Syst Biol, Bioinformatics
  • Education: PhD, Chemistry and Biochemistry, University of Texas at Austin. Postdoctoral Fellowship, University of Washington.

Nicole Kounalakis, Associate Member, Molecular Oncology Program

Assistant Professor, Surgery, University of Colorado School of Medicine

  • Working in Breast Cancer, Skin Cancer
  • Research Focus: Surgical oncology clinical trials and outcomes
  • Collaborators: Drs. William Robinson, Rene Gonzalez, Martin McCarter
  • Select Publications in Ann Surg Oncol, J Surg Res
  • Education: MD, University of Medicine and Dentistry-Newark (UMDNJ). General Surgery Internship, UMDNJ. Surgical Residency, UMDNJ-Robert Wood Johnson Medical School. Surgical Oncology Fellowship, City of Hope National Medical Center.

Elaine Lam, MD, Associate Member, Developmental Therapeutics Program

Assistant Professor, Medical Oncology, University of Colorado School of Medicine

  • Working in Bladder Cancer, Prostate Cancer, Renal/Kidney Cancer, Developmental Therapeutics
  • Research Focus: Development of novel targeted agents
  • Select Publications in Mol Cancer Ther, Caner Chemother Pharmacol, J Clin Oncol
  • Education: MD, University of Colorado School of Medicine. Internship and Residency, University of Colorado Denver. Clinical Fellowship in Hematology/Oncology, The Ohio State University.

Kelly Maloney, MD, Member, Developmental Therapeutics Program

Associate Professor, Pediatric Hematology/Oncology/Bone Marrow Transplant, University of Colorado School of Medicine
Director of Clinical Research, The Children’s Hospital Center for Cancer and Blood Disorders

  • Working in Pediatric Cancer
  • Research Focus: acute lymphoblastic leukemia clinical trials and other pediatric cancer trials
  • Select Publications in Pediatr Blood Cancer and Blood
  • Education: MD, University of Colorado School of Medicine. Internship and Residency in Pediatrics; Fellowship and Postdoctoral Fellowships in Pediatric Hematology/Oncology/BMT, The Children’s Hospital

Borsika Rabin, PhD, MPH, PharmD, Member, Cancer Prevention & Control Program

Affiliate Assistant Professor, Colorado School of Public Health
Staff Researcher, Cancer Research Network Communication Research Center, Kaiser Permanente Colorado

  • Working in GI Cancer, Prostate Cancer, Cancer Survivorship
  • Research Focus: Factors associated with dissemination and implementation of evidence-based interventions for cancer prevention. Communication and coordination in survivorship. Web-based cancer interventions and tools.
  • Select Current Funding: NCI-CRN Cancer Communication Research Center, “Development of an Online Dissemination Planning Tool.” NCI P20, “Stage One Feasibility Testing of the Cancer Survival Query System.”
  • Select Publications in Clinical Medicine and Research, Implementation Science, Am J of Prev Med
  • Education: PharmD, Semmelweis University Faculty of Pharmacy, Hungary. MPH, St. Louis University School of Public Health. PhD, St. Louis University School of Public Health.

Alanna Rahm, PhD, Associate Member, Cancer Prevention & Control Program

Senior Project Manager and Principal Investigator, Institute for Health Research, Kaiser Permanente Colorado

  • Working in Breast Cancer, GI Cancer, Hereditary Cancer, Survivorship
  • Research Focus: Hereditary cancer genetic risk and direct-to-consumer genetics.
  • Current Funding: NIH/CRN, “Media coverage and direct-to-consumer advertising of genetic tests.”
  • Recent Publications: J Contin Educ Health Prof, Perm J,  J Genet Couns
  • Education: PhD, Health and Behavioral Science, University of Colorado Denver. MS, Biophysics and Genetics/Genetic Counseling, University of Colorado Health Sciences Center.

Debra Ritzwoller, PhD, Member, Cancer Prevention & Control Program

Research Scientist and Health Care Economist, Institute for Health Research, Kaiser Permanente Colorado

  • Working in Breast Cancer, Prostate Cancer, Thoracic Oncology, Radiation Oncology, Cancer Survivorship
  • Research Focus: Economics of cancer care, health care data systems issues related to capture and analysis of cancer treatment data within managed care systems, cost-sharing and benefit generosity across the spectrum of cancer care.
  • Select Current Funding: NCI Cancer Research Network. ACS, “High Deductible Health Plans and the Receipt of Cancer Prevention Services.” NCI RC2, “Building CER Capacity: Aligning CRN, CMS, and State Resources to Map Cancer Care.” NCI RC2, “Cancer Research Network Across Health Care Systems.”
  • Select Recent Publications: Med Care, Health Promot Pract, Ann Behav Med.
  • Education: PhD, Economics, University of Colorado Boulder. MA, Economics, University of Colorado Boulder.

Hugo Rosen, MD, Associate Member, Cancer Cell Biology Program

Professor and Head, Gastroenterology and Hepatology, University of Colorado School of Medicine
Waterman Professor of Medicine and Immunology, University of Colorado Denver

  • Working in GI/Liver Cancer
  • Research Focus: Multi-cellular immune response to hepatitis C virus, and targets for novel immunotherapies in hepatocellular carcinoma
  • Select Current Funding: VA Merit Review Immunology Study Section: “Functional Attributes of HCV-specific CTLs.” NIH RO1, “Innate Immune Responses During Therapy for Chronic HCV.” HCV Center Grant, “Immune Escape Strategies in Hepatitis C Infection.”
  • Select Publications in J Clinical Invest, J Infect Dis, PLoS Pathog, Hepatology
  • Education: MD, University of Miami. Internal Medicine Internship and Residency, Beth Israel-Deaconess Hospital, Harvard Medical School. Fellowship in Gastroenterology and Hepatology, University of California Los Angeles.

Isabel Schlaepfer, PhD, Associate Member, Hormone Related Malignancies Program

Instructor/Fellow, Endocrinology, University of Colorado School of Medicine

  • Working in Breast Cancer, Prostate Cancer
  • Research Focus: Lipid metabolism pathways in breast and prostate cancer.
  • Collaborators: Drs. Robert Eckel, Kathryn Horwitz, Britta Jacobsen, Michael Glodé and Natalie Serkova.
  • Current Select Funding: American Cancer Society Postdoctoral Fellowship, “Role of Munc18c proteins in cancer and insulin resistance.” Avon Foundation for Women, “Lipogenesis in Breast Cancer Cells.”
  • Select Publications in American Journal of Physiology.
  • Education: PhD, Integrative Physiology, University of Colorado Boulder. MA, Biology, University of Colorado Denver.

Lisa Thompson, PharmD, Associate Member, Developmental Therapeutics Program

Assistant Professor, Clinical Pharmacy, University of Colorado School of Pharmacy

  • Works in: Developmental Therapeutics, GI Cancer
  • Research Focus:Estimating empirc chemotherapy doses for obese cancer patients, optimizing methods o patietn educaton regarding cacner treatment, methods to improve supportive care and pharmacokinetic studies of anticancer agents in special populations.
  • Select Publications in Journal of Oncology Practice
  • Education: PharmD, University of Kentucky. Pharmacy Residency and Hematology/Oncology Specialty Residency, University of Kentucky HeatlthCare.
FacebookTwitterGoogle+Share

About the author: Lynn Clark

Lynn G. Clark is the former communications manager for the University of Colorado Cancer Center and owner of Lynn Clark Photography. Reach her at lynn [at] lynnclarkphotography.com.

1 comment

  1. James says:

    Congratulations to all those 18 members. Good information is given about them.